Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06610539Recruiting

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

Role: collaborator

NCT03020888Not ApplicableCompleted

Magseed Magnetic Marker Localization

Role: lead

NCT02635737Not ApplicableCompleted

Magnetic Seed Localisation of Breast Cancers

Role: collaborator

NCT02336737Not ApplicableCompleted

SentiMag® Intraoperative Comparison in Breast Cancer

Role: lead

All 4 trials loaded